The US Food and Drug Administration's inspection of RIJ Pharmaceutical LLC in 2018 a month before the private label manufacturer recalled OTC cough and cold products due to contaminated water launched a process that could lead to the firm closing its facility for remediation.
An FDA warning letter published April 16 says RIJ has not shown its water system can consistently produce water suitable...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?